About

MacDonald Fact Sheet

Download the UH MacDonald Women's Hospital Fact Sheet (PDF)

At a Glance

Opened in 1891 as the Maternity Hospital of Cleveland, today University Hospitals MacDonald Women’s Hospital is synonymous with excellence in clinical research, medicine and patient care. Located on the campus of University Hospitals Case Medical Center in Cleveland, Ohio, UH MacDonald Women’s Hospital is Ohio’s only hospital dedicated solely to women’s health. Renowned as a leading center in women’s health research, UH MacDonald Women’s Hospital offers comprehensive care and the latest medical advancements through a dedicated, multidisciplinary team of experts in maternal fetal medicine, obstetrics and gynecology, female pelvic medicine and surgery, gynecologic oncology, reproductive endocrinology and infertility, behavioral medicine, midwifery and breast care.

2014 Statistics

Hospital founded: 1891
Licensed adult beds: 93
Nursery bassinets: 48
Medical staff: 61
Residents/fellows: 29
Inpatient discharges (adult): 6,486
Births: 4,508
Outpatient visits: 85,118
Surgical cases: 2,105
Total days of care: 14,118
Average length of stay: 2.8
Charity care: $49 million (University Hospitals, 2013)

Quality outcomes/Evidence-based labor practices

Primary CD rate: 23.5 percent
(Primary cesarean rate in low-risk women. State average is 26.3 percent.)
Preterm delivery without medical indication: 1.9 percent (State average is 4.1 percent.)
Episiotomy: 1.5 percent (State average is 10.4 percent.)
TOLAC/VBAC: 57 percent/59 percent
(Successful trial of labor/vaginal birth after cesarean. State average is 10.4 percent.)
Steroid administration for preterm delivery: 100 percent

Department chairman

James H. Liu, MD
Arthur H. Bill Professor, Case Western Reserve University School of Medicine

Address

University Hospitals Case Medical Center
11100 Euclid Avenue
Cleveland, OH 44106
Phone: 216-844-3941

Awards

  • Ranked one of America’s Best Hospitals for Gynecology by U.S. News & World Report
  • 2014 designated Baby Friendly by Baby Friendly USA
  • 2013 recipient of International Board Certified Lactation Consultant (IBCLC) certificate
  • 2012 recipient of Gold Award in Employer Breastfeeding Award, Ohio Department of Health
  • 2012 National Bestfed Beginnings Breastfeeding Friendly Hospital winner

Medical/surgical services

  • Behavioral Medicine
  • Female Pelvic Medicine & Reconstructive Surgery
  • General Obstetrics & Gynecology
  • Gynecologic Oncology
  • Maternal Fetal Medicine
  • Midwifery
  • Neonatology
  • Reproductive Endocrinology & Infertility

Specialty programs and clinics

  • Bleeding Disorders
  • Centering Pregnancy
  • Family Planning Center
  • Preconception Planning Clinic
  • Center for Diabetes in Pregnancy
  • Sexual Function & Vulvovaginal Health Center
  • Fibroid Clinic
  • Centering Parenting
  • PCOS Clinic
  • Pediatric & Adolescent Gynecology Clinic
  • UH Fertility Center
  • Sickle Cell Clinic

National Institutes of Health Research and Extramural Grants

March of Dimes Prematurity Research Collaborative of Ohio
Co-Principal Investigator: Sam Mesiano, PhD

ERV3 Control of human placentation
Principal Investigator: Neal Rote, PhD

Role of nuclear progesterone receptors in the control of human parturition
Principal Investigator: Sam Mesiano, PhD

Development of gene-specific progesterone receptor modulators to prevent preterm birth
Principal Investigator: Sam Mesiano, PhD

Gynecologic Oncology Foundation
Principal Investigator: Steven Waggoner, MD

NRG Oncology
Principal Investigator: Steven Waggoner, MD

NCI National Clinical Trials Network (NCTN)
Lead Academic Participating Site (LAPS)
Gynecologic Oncology Team Leader: Steven Waggoner, MD

NICHD Contraceptive Clinical Trials Network
Principal Investigator: James Liu, MD

NICHD Maternal-Fetal Medicine Units (MFMU) Network Site
Principal Investigator: David Hackney, MD

Neurophysiologic & autonomic characterization of interstitial cystitis/painful bladder syndrome
Co-Principal Investigators: Jeffrey Janata, PhD, and Sangeeta Mahajan, MD

Efficacy and safety of subcutaneously administered bremelanotide in premenopausal women with hypoactive sexual desire disorder
Principal Investigator: Angelina Gangestad, MD

Safety and efficacy of TX-004HR in postmenopausal women with moderate to severe symptoms of vulvar and vaginal atrophy
Principal Investigator: Angelina Gangestad, MD

Contraceptive efficacy, safety and tolerability of the AG200-15 transdermal contraceptive delivery system
Principal Investigator: Angelina Gangestad, MD

Make an Appointment

Schedule your appointment with a specialist at University Hospitals.
1-866-UH4-CARE

More Scheduling Options

Need to Refer a Patient?

Click here for Patient Referrals

Better Living Blog

How much protein is enough? Should you strength train as you age? How to fight fatique? The answer to these questions and many others are contained in our monthly "Better Living" blog. For a FREE subscription, visit our Sign Up page.

Sign Up Now

Browse Services A-Z

Maps and Directions

Click here for directions